Condition detail

Hyperlipidemia

Hyperlipidemia is a lipid-management condition involving cholesterol or triglyceride levels, typically followed with lipid panels, cardiovascular risk factors, nutrition/activity context, and medicines such as statins when prescribed.

Endocrine / metabolic ID 222
Hyperlipidemia reference image: An anatomical illustration of adipose tissue.
Image: Blausen 0012 AdiposeTissue.png by BruceBlaus, CC BY 3.0.
Common Tracking

Track glucose if relevant, A1C, weight, blood pressure, medicines, energy, thirst, urination, labs, nutrition context, and clinician goals.

Connected records

Database matches for this condition

Fatigue reference image: A person jogging outdoors.
Image: Jogging Woman in Grass.jpg by Mike Baird, CC BY 2.0.

Fatigue

Fatigue is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.

General / systemic Whole body
Medication side effects reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.

Medication side effects

Medication side effects is a possible medicine, injection, allergy, or exposure-related symptom that is useful to record with timing, dose, route, and product details.

Medication / allergy Medication safety
Muscle weakness reference image: An anatomical illustration of the knee joint.
Image: Blausen 0596 KneeAnatomy Front.png by BruceBlaus, CC BY 3.0.

Muscle weakness

Muscle weakness is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.

Musculoskeletal Bones / joints / muscles
colesevelam hydrochloride reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.

Colesevelam hydrochloride

Used for: Colesevelam hydrochloride is a bile acid sequestrant indicated as an adjunct to diet and exercise to: reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia ( 1.1 ). reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (HeFH), unable to reach LDL-C target levels despite an adequate trial of diet and lifestyle modification ( 1.1 ).

Lipid-lowering medicine
ezetimibe reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.

Ezetimibe

Used for: Ezetimibe tablets are indicated: • In combination with a statin, or alone when additional low-density lipoprotein cholesterol (LDL-C) lowering therapy is not possible, as an adjunct to diet to reduce elevated LDL-C in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH). • In combination with a statin as an adjunct to diet to reduce elevated LDL-C in pediatric patients 10 years of age and older with HeFH.

Cholesterol absorption inhibitor
phentermine hydrochloride reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.

Phentermine hydrochloride

Used for: Phentermine hydrochloride is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥ 30 kg/m 2 , or ≥ 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). Below is a chart of body mass index (BMI) based on various heights and weights.

Lipid-lowering medicine